LONDON, June 30 /PRNewswire/ -- Two-dimensional electrophoresis (2DE) is the most cost-effective protein profiling technology and is the only technology in which the constituents of a protein sample can be entirely visualised in a single gel. However, current technical limitations will need to be effectively tackled for these advantages to be leveraged and market growth to be maximised.
New analysis from Frost & Sullivan (http://www.drugdiscovery.frost.com), European 2-Dimensional Electrophoresis Market, finds that the market earned revenues of about $130.0 million in 2008 and estimates this to reach nearly $159.2 million in 2015. The following segments are covered in the research: two-dimensional gel electrophoresis, liquid chromatography and mass spectrometry.
If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Katja Feick, Corporate Communications, at firstname.lastname@example.org, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brief brochure will be sent to you by e-mail.
"The global recession is bound to affect government research spending which is like oxygen to academic researchers," remarks Frost & Sullivan Research Analyst Rasika Ramachandran. "The current economic situation is therefore a blessing in disguise for the 2DE industry as researchers will be on the prowl for cheaper technologies in a cash-crunched climate. Participants in the market should capitalise on the prevailing situation to improve their revenues."
The European 2DE market is projected to grow at a better rate in the near term, as academic researchers - the main consumers of these products - are likely to invest more in cheaper alternatives for protein expression studies, such as 2DE.
Sample preparation solutions are never 'one-size-fits-all' and can vary dramatically from one kind of sample to the other. They can also differ depending on which part of the proteome the researcher wants to study.
Companies therefore find it very difficult to come out with sample preparation kits that will effectively address the varied needs of the market. A large number of products are required to address this market, but each of these products will enjoy only a limited response due to the differing needs of customers.
"Sample preparation is a major challenge that the industry needs to overcome," states Ramachandran. "It affects both the reproducibility and the resolution of the 2DE experiment which, in turn, influences the end results."
It is advisable for market participants to focus on determining the kinds of samples that are the most widely studied in the market. Following this, a feasibility analysis to check the financial viability of developing a sample preparation kit for such samples should be conducted. This can help market participants to more effectively fulfill varied sample requirements.
However, the industry has to consider that customers need to be provided strong technical support. This aspect, therefore, also has to be factored into any feasibility study related to the development of sample preparation kits.
"Industry participants need to address the sample preparation market in a more consolidated manner, whereby every sample preparation kit developed by each company should effectively address a unique niche," advises Ramachandran. "This strategy will ensure that participants do not cannibalise each other's customer base."
European 2-Dimensional Electrophoresis Market is part of the Drug Discovery & Clinical Diagnostics Growth Partnership Services programme, which also includes research in the following markets: Opportunities for the European Mass Spectrometry Market in Basic Research Applications and European Protein Purification Markets. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
European 2-Dimensional Electrophoresis Market
Contact: Katja Feick Corporate Communications - Europe P: +49 (0) 69 7703343 E: email@example.com
|SOURCE Frost & Sullivan|
Copyright©2009 PR Newswire.
All rights reserved